Analyze Diet
Veterinary immunology and immunopathology1994; 42(3-4); 221-235; doi: 10.1016/0165-2427(94)90069-8

Proteins induced by recombinant equine interferon-beta 1 within equine peripheral blood mononuclear cells and polymorphonuclear neutrophilic granulocytes.

Abstract: Peripheral blood mononuclear cells (PBMC) and polymorphonuclear neutrophilic granulocytes (PMN) as well as embryonic equine dermal fibroblasts and the equine fibroblast line E. Derm which were used as controls, were treated with recombinant equine interferon-beta 1 (rEqIFN-beta 1) in vitro which induced the expression of different proteins in these cells. A 74 kDa protein was induced in PBMC and an 82 kDa protein was additionally found in the equine fibroblast E. Derm cell line following treatment with rEqFN-beta 1. Both proteins reacted with anti-mouse and anti-human Mx protein antisera in immunoblot tests. The 74 kDa and perhaps the 82 kDa components may thus represent equine 'Mxanalogous proteins'. The 74 kDa protein was only detected in PBMC of ten out of 20 horses examined. The induction of Mx protein in the horse by Type 1 interferon may therefore resemble that in the mouse, where Mx protein is involved in selective resistance to influenza virus. The influence of rEqIFN-beta 1 on protein expression in equine PBMC and PMN was monitored by metabolic labeling and 2-D gel electrophoresis. Proteins of 82, 74, 58 and 40 kDa were induced in PBMC following exposure to rEqIFN-beta 1. A constitutively expressed 35 kDa protein, however, was no longer demonstrable upon treatment with interferon. None of the proteins induced within PBMC was found in highly purified PMN treated with interferon. PMN exposed to rEqIFN-beta 1 synthesized four proteins in the range of 25 to 27 kDa. These proteins have not been described in interferon-treated PMN of any other species.
Publication Date: 1994-09-01 PubMed ID: 7810057DOI: 10.1016/0165-2427(94)90069-8Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research examines the proteins induced in horse cells when treated with a specific type of interferon (a signaling protein in immune response). This study identifies specific proteins that respond to the interferon treatment and suggests these proteins might be similar to another protein involved in immune resistance to influenza virus.

Understanding the Cells and Interferon Used

  • The study involves different cell types – Peripheral blood mononuclear cells (PBMC), polymorphonuclear neutrophilic granulocytes (PMN), equine dermal fibroblasts and equine fibroblast E. Derm. The latter two types were used as controls.
  • The cells were treated with recombinant equine interferon-beta 1 (rEqIFN-beta 1). Interferons, such as rEqIFN-beta 1, play a crucial role in the immune response.

Results Let To ‘Mx Analogous Proteins’

  • When the cells were exposed to rEqIFN-beta 1, it induced the production of proteins – 74 kDa protein was found in PBMC and an 82 kDa protein was found in the E. Derm cell line.
  • Both proteins showed a reaction when tested with anti-mouse and anti-human Mx protein antisera. The proteins were thus named ‘Mx analogous proteins’ due to this similarity.
  • However, the study found that the 74 kDa protein was detected only in the PBMC of half the horses tested, indicating that the protein induction might show variation across the horse population.

Effects of rEqIFN-beta 1 on Protein Expression

  • Monitoring the effects of rEqIFN-beta 1 on protein expression in PBMC and PMN revealed that proteins of 82, 74, 58 and 40 kDa were induced in PBMC following rEqIFN-beta 1 treatment. A 35 kDa protein, however, disappeared after the interferon treatment.
  • None of these proteins were present in PMN when treated with interferon, suggesting a distinct difference in response between PBMC and PMN cells. The PMN instead synthesized proteins ranging 25 to 27 kDa in response to treatment.
  • Interestingly, these proteins found in interferon-treated PMN have not been reported in any other species.

Significance and Implications

  • The study builds understanding in how equine cells respond to interferon treatment and gives insight on how this can be connected to defence mechanisms against viruses like influenza, which is significant in understanding resistance mechanisms in different species.
  • Finding proteins that have not been described in any other species suggests the possibility of unique immune response pathways in horses, opening the path for further study.

Cite This Article

APA
Heinz H, Marquardt J, Schuberth HJ, Adolf GR, Leibold W. (1994). Proteins induced by recombinant equine interferon-beta 1 within equine peripheral blood mononuclear cells and polymorphonuclear neutrophilic granulocytes. Vet Immunol Immunopathol, 42(3-4), 221-235. https://doi.org/10.1016/0165-2427(94)90069-8

Publication

ISSN: 0165-2427
NlmUniqueID: 8002006
Country: Netherlands
Language: English
Volume: 42
Issue: 3-4
Pages: 221-235

Researcher Affiliations

Heinz, H
  • Immunology Unit, Veterinary School, Hannover, Germany.
Marquardt, J
    Schuberth, H J
      Adolf, G R
        Leibold, W

          MeSH Terms

          • Animals
          • Antiviral Agents / biosynthesis
          • Cell Line
          • Female
          • Fibroblasts / drug effects
          • GTP-Binding Proteins
          • Horses / blood
          • Interferon-beta / pharmacology
          • Leukocytes, Mononuclear / drug effects
          • Leukocytes, Mononuclear / metabolism
          • Male
          • Myxovirus Resistance Proteins
          • Neutrophils / drug effects
          • Neutrophils / metabolism
          • Protein Biosynthesis
          • Recombinant Proteins / pharmacology
          • Skin / drug effects

          Citations

          This article has been cited 2 times.
          1. Bayrou C, Van Laere AS, Dam Van P, Moula N, Garigliany MM, Desmecht D. Anti-Schmallenberg Virus Activities of Type I/III Interferons-Induced Mx1 GTPases from Different Mammalian Species. Viruses 2023 Apr 25;15(5).
            doi: 10.3390/v15051055pubmed: 37243140google scholar: lookup
          2. Fatima U, Zhang Z, Zhang H, Wang XF, Xu L, Chu X, Ji S, Wang X. Equine Mx1 Restricts Influenza A Virus Replication by Targeting at Distinct Site of its Nucleoprotein. Viruses 2019 Dec 2;11(12).
            doi: 10.3390/v11121114pubmed: 31810278google scholar: lookup